Stocktoria
Fresenius Medical Care AG FMS
Fresenius Medical Care AG financials (annual)
Bars are annual figures from 2008 to 2016; red bars are negative (a loss or cash outflow).
| Metric | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $5.3B | $5.0B | — | — | — | — | — |
| Gross profit | $5.8B | $5.3B | $5.0B | $4.7B | $4.6B | $4.2B | $3.8B | $3.8B | $3.6B |
| R&D expense | $162.4M | $140.3M | $122.1M | $125.8M | $111.6M | $110.8M | $96.5M | $93.8M | $80.2M |
| SG&A expense | $3.0B | $2.9B | $2.6B | $2.4B | $2.2B | $2.0B | $1.8B | $2.0B | $1.9B |
| Operating income | $2.6B | $2.3B | $2.3B | $2.3B | $2.2B | $2.1B | $1.9B | $1.8B | $1.7B |
| Interest expense | $452.2M | $508.0M | $495.4M | $447.5M | $470.5M | $356.4M | $305.5M | $321.4M | $361.6M |
| Income tax | $683.1M | $622.1M | $583.6M | $592.0M | $605.1M | $601.1M | $578.3M | $490.4M | $475.7M |
| Net income | $1.2B | $1.0B | $1.0B | $1.1B | $1.2B | $1.1B | $978.5M | $891.1M | $817.6M |
| EPS (diluted) | $4.06 | $3.38 | $3.45 | $3.65 | $3.87 | $3.51 | $3.24 | $2.99 | $2.74 |
| Operating cash flow | $2.1B | $2.0B | $1.9B | $2.0B | $2.0B | $1.4B | $1.4B | $1.3B | $1.0B |
| Free cash flow | $1.1B | $1.0B | $929.8M | $1.3B | $1.4B | $848.6M | $844.5M | $765.0M | $329.0M |
| Cash & equivalents | $747.2M | $549.5M | $633.9M | $682.8M | $688.0M | $457.3M | $522.9M | $301.2M | $221.6M |
| Inventory | $1.4B | $1.3B | $1.1B | $1.1B | $1.0B | $967.5M | $809.1M | $821.7M | $707.0M |
| Total assets | $26.9B | $25.4B | $25.4B | $23.1B | $22.3B | $19.5B | $17.1B | $15.8B | $14.9B |
| Total liabilities | $14.2B | $13.8B | $14.5B | $13.0B | $12.6B | $11.1B | $9.3B | $8.8B | $8.8B |
| Shareholders' equity | $11.5B | $10.5B | $10.0B | $9.5B | $9.2B | $8.1B | $7.5B | $6.8B | $6.0B |
Growth · year-over-year · Revenue CAGR 5.9%
| Metric | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | +5.9% | — | — | — | — | — | — |
| Net income growth | +20.8% | -1.5% | -5.8% | -6.5% | +10.8% | +9.5% | +9.8% | +9.0% | — |
| EPS growth | +20.1% | -2.0% | -5.5% | -5.7% | +10.3% | +8.3% | +8.4% | +9.1% | — |
| Free cash flow growth | +10.2% | +8.3% | -27.7% | -5.6% | +60.7% | +0.5% | +10.4% | +132.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2016-12-31. Facts plus Stocktoria's own computed scores — not investment advice.